Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects

NCT00146328 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00146328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2001
Completion date
Not reported
Enrollment
997 (actual)
Sites
233

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections